Approval · Notice of Compliance 20058 · 2017
ORFADIN: Notice of Compliance 20058
Issued November 14, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20058
- Date
- November 14, 2017
- Company
- Swedish Orphan Biovitrum Ab (Publ)Stockholm, Sweden
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORFADIN | 02469693 | Marketed |
Medicinal ingredients
- NITISINONE 4 MG per ML